Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in LENZ — LENZ Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to LENZ Full portfolio

Position in LENZ

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$68,050
-$31,528 QoQ
Shares Held
11,981
+10.1% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 23% Shared 0% None 77%

Common Shares in LENZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,192 across 425 Biotechnology names. LENZ ranks #289 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in LENZ

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $68,050 11,981
2026-03-31 $99,578 10,883
2025-12-31 $151,440 9,465
2025-09-30 $522,719 11,222
2025-06-30 $303,679 10,361
2025-03-31 $206,989 8,051
2024-12-31 $240,831 8,342
2024-09-30 $135,293 5,699
2024-06-30 $93,711 5,420
2024-03-31 $37,558 1,682